The $1.6 Billion Gamble: Rubio's Plan to Route US Health Aid Directly Through Kenya's Government — and Why Courts Hit the Brakes

On December 4, 2025, Secretary of State Marco Rubio and Kenyan President William Ruto signed a Health Cooperation Framework in Washington, D.C. that committed $2.5 billion over five years — $1.6 billion from the United States, $850 million from Kenya — to be channeled directly through Kenyan government institutions rather than international NGOs [1][2]. It was the first agreement under the administration's "America First Global Health Strategy," and Rubio framed it as the end of an era. "We will not spend billions of dollars funding the NGO industrial complex," Rubio said, arguing that if the goal is to help a country, the US should work with that country, "not with a third party that imposes things on that country" [3].

Four months later, the deal is frozen. Kenya's High Court suspended first the data-sharing provisions and then the entire agreement, finding credible legal questions about constitutional privacy violations, breaches of data protection statutes, and insufficient parliamentary oversight [4]. The case has become a stress test not just for Kenya, but for the 30 countries that have signed similar bilateral agreements — and for the broader question of whether dismantling the NGO infrastructure that delivers US health aid will improve outcomes or gut them.

The Scale of What's at Stake

The United States is Kenya's largest bilateral health donor. Between 2020 and 2025, USAID committed approximately $2.5 billion in foreign assistance to Kenya, with roughly 80 percent allocated to health programs [5]. In fiscal year 2023, total US aid to Kenya exceeded $846 million in obligations, rising to $932 million in FY2024 [6].

The bulk of this money has flowed through NGOs. According to AidData, over 1,000 US-based NGOs operating in Kenya contributed approximately $270 million per year, while multilateral organizations, foreign NGOs, and US-based businesses together accounted for 58 percent of all implementing partner funds [5]. Under the existing model, PEPFAR — the President's Emergency Plan for AIDS Relief — operates through more than 100 implementing partners in Kenya [7].

Source: PEPFAR Kenya / U.S. Embassy

Data as of Jan 1, 2024CSV

The numbers behind PEPFAR in Kenya are not abstract. In FY2023 alone, PEPFAR-supported programs provided antiretroviral treatment to nearly 1.3 million people, tested over 3 million Kenyans for HIV, and supported care for more than 608,000 orphans and vulnerable children [7]. Approximately 41,500 health workers — roughly 18 percent of Kenya's entire healthcare workforce — are funded through US programs [8]. Since 2003, the United States has invested at least $8 billion in Kenya's HIV response, contributing to a 78 percent reduction in new infections and a 68 percent decline in AIDS-related deaths since 2013 [7].

Where the Money Would Go

Under the new framework, US funds would flow directly into Kenyan government systems: the Social Health Authority (SHA), the Digital Health Authority (DHA), the Kenya Medical Supplies Authority (KEMSA), the Integrated Financial Management Information System (IFMIS), the Ministry of Health, and the newly established National Public Health Institute [2].

Several of these entities carry significant baggage. KEMSA, designated as the primary conduit for medical supplies, was at the center of a $72 million procurement scandal in 2020 involving COVID-19 personal protective equipment. Investigations found the agency flouted procurement laws and awarded tenders to politically connected companies, prompting then-President Uhuru Kenyatta to dissolve its board [9]. In a separate case, KEMSA was implicated in a botched $27 million mosquito net procurement, leading President Ruto to sack the public health principal secretary and the entire KEMSA board [10]. In 2024, the United States itself indicted a Kenyan national in connection with a $650 million scheme to divert US-funded HIV test kits and medical supplies distributed through KEMSA [11].

As of early 2026, KEMSA is struggling with a $55 million debt that has pushed it into a liquidity crisis, leaving public hospital shelves empty [12].

Source: Transparency International

Data as of Jan 1, 2024CSV

Kenya scored 31 out of 100 on Transparency International's 2023 Corruption Perceptions Index, placing it in the bottom third of all countries ranked [13]. For context, among the countries that have signed the largest America First bilateral health agreements, Nigeria scored 25 and the DRC scored 20, while Botswana — which scored 55 — negotiated a deal requiring 78 percent of total funding to come from its own domestic contributions [14]. The corruption track record raises a basic empirical question: what happens when more money flows through government systems with documented accountability failures?

The Legal Collision

The framework was negotiated without public disclosure of its terms, stakeholder notification, civil society input, or parliamentary oversight [4]. Busia Senator Okiya Omtatah filed a court petition seeking to halt implementation, arguing that channeling funds directly through government systems without third-party oversight exposes resources to potential mismanagement [15]. The Consumer Federation of Kenya joined the challenge, focusing on health data privacy [15].

Kenya's Data Protection Act of 2019 classifies health data as sensitive personal data requiring strict cross-border transfer protections. The Digital Health Act of 2023 mandates health data localization within Kenya [4]. The framework, however, institutionalizes foreign access to surveillance systems, electronic medical records, and genomic and pathogen information — what the Carnegie Endowment for International Peace described as arrangements that risk "entrenching data-extractive dynamics" [4]. Nearly 50 civil society organizations warned of these risks before the court intervened [4].

The deal also requires Kenya to amend its regulations by December 31, 2026, to recognize US Food and Drug Administration approvals as meeting all requirements of the Pharmacy and Poisons Board — a provision that critics argue shifts regulatory authority away from Kenyan institutions [16].

The High Court's ruling found credible constitutional concerns and suspended the entire agreement. Zimbabwe subsequently rejected a similar deal citing data-sharing concerns, and Zambia raised questions during negotiations [4].

The Legal Authority Question

The Foreign Assistance Act of 1961 provides the statutory framework for most US foreign assistance. It authorizes the president to determine the "terms and conditions" of aid delivery [17]. Historically, Congress has attached earmarks and conditions — particularly around PEPFAR — that require implementation through civil society organizations or specified multilateral channels.

The administration's ability to redirect aid delivery without congressional action rests on executive discretion over implementation mechanisms. But key statutory constraints remain. PEPFAR's authorizing legislation contains specific provisions about implementation partners. The GAO has already found that the current administration violated spending laws through illegal impoundments of appropriated funds in other contexts [18]. Whether the wholesale restructuring of delivery channels constitutes a permissible exercise of executive authority or an end-run around congressional intent remains an open legal question — one that NGO advocates and some members of Congress have begun to raise.

The Steelman Case Against NGOs

The administration's critique of the NGO model is not without supporting evidence. Rubio's central claim is that NGO overhead consumes funds that should reach beneficiaries, and that the existing system marginalizes host-country governments from decisions about their own healthcare [3].

A 2002 GAO report found that USAID "relies heavily on nongovernmental organizations" but lacked adequate data to evaluate whether NGO-delivered aid was more effective than alternatives [19]. More recently, USAID's own internal reviews have acknowledged that localization — shifting implementation to local organizations and government systems — is a stated goal. The agency's 2022 localization targets called for 25 percent of funding to flow through local partners by 2025, an implicit acknowledgment that the existing model was too reliant on international intermediaries [5].

Independent evaluations have found instances of NGO mission creep, duplicated programming, and administrative costs that vary widely — from under 10 percent to over 30 percent of program budgets depending on the organization and program type. The World Bank has documented cases where parallel NGO systems in health delivery created coordination failures with government programs and undermined long-term institutional capacity [20].

Kenya's own health officials have at times echoed these concerns. The framework's proponents argue that direct government funding builds sustainable systems rather than creating permanent dependence on external implementing partners [2].

The Case for Keeping NGOs in the Loop

The counterarguments are equally grounded in evidence. NGOs serve a dual function in aid delivery: they implement programs, and they monitor how money is spent. Removing them from the equation eliminates an independent accountability layer in countries where government institutions have documented corruption problems [15].

In Kenya specifically, the USAID Office of Inspector General has conducted multiple financial audits of aid resources and investigated allegations of large-scale fraud and money laundering [21]. These investigations were possible in part because NGO implementing partners maintain their own financial reporting systems that create auditable paper trails. Direct government-to-government aid relies on host-country audit institutions — which, in Kenya's case, have themselves been subject to political pressure.

Kenya's Council of Governors, representing the country's 47 counties, said it was not consulted on the deal. County health directors warned that the arrangement echoes past instances where the national government made major health spending decisions without county input and then "offloaded the costs onto the counties" [16]. Under Kenya's devolved health system, counties bear primary responsibility for healthcare delivery — yet the framework routes funds through national-level entities.

The practical transition risks are acute. Approximately 41,500 health workers currently funded through US programs would need to be absorbed into government payroll systems [8]. Early evidence from the 2025 USAID funding cuts is not encouraging: PEPFAR-supported drop-in centers for community-based HIV monitoring were suspended, several antiretroviral therapy clinics closed without referral systems, and community-led HIV prevention outreach was halted [8]. Health workers in some facilities went months without pay after US funding was cut [22].

The Broader DOGE-Era Restructuring

The Kenya deal does not exist in isolation. It is the flagship of a sweeping restructuring of US foreign aid driven by the administration's broader cost-cutting and efficiency agenda.

USAID was officially closed on July 1, 2025, with remaining programs transferred to the State Department under Rubio's authority [23]. The Department of Government Efficiency (DOGE), launched in January 2025 under Elon Musk's direction, played a central role in the initial shutdowns — closing USAID's Washington headquarters on February 3, 2025, and initiating the fold of the agency into State [23]. After Musk departed Washington in June, DOGE's functions were absorbed by the Office of Management and Budget [23].

The fiscal impact has been stark. US foreign aid spending fell from $68 billion in 2024 to $32 billion in 2025 — a cut of more than half [23]. The proposed 2026 global health budget of $3.8 billion represents a 60 percent decrease from actual 2025 spending [24]. As of April 2025, 81 NGOs had closed at least one office due to funding disruptions [23].

Source: KFF Tracker

Data as of Apr 7, 2026CSV

As of April 2026, 30 countries have signed bilateral health MOUs under the America First strategy, with total commitments exceeding $16 billion [14]. Nigeria leads with a $5.054 billion framework, followed by Kenya at $2.481 billion and Mozambique at $1.9 billion [14]. The agreements vary significantly in their co-investment requirements: Botswana committed 78 percent of its deal's total value from domestic funds, while Guatemala committed just 2.6 percent [14].

Historical Precedents: Uganda and Ethiopia

The administration presents direct government-to-government aid as an innovation. But the model has been tested before — with mixed results.

In the 2000s, Uganda and Ethiopia were considered "donor darlings" that received substantial untied budget support, allowing their governments to allocate and spend according to their own priorities [25]. The Overseas Development Institute found that budget support enabled concrete achievements in scaling up service delivery and reducing poverty in both countries [25]. In Uganda, aid was associated with increased tax collection and public spending, and reduced domestic borrowing [26].

But the model's limitations became clear during political crises. When both governments cracked down on opposition forces ahead of elections, donors had limited tools to respond because funds were already embedded in government systems [25]. The UK and other donors eventually suspended direct budget support to Uganda after corruption scandals in the Office of the Prime Minister, where aid funds were diverted to private accounts [25]. The experience led most major donors to move away from direct budget support and toward the NGO-mediated model that Rubio now seeks to dismantle.

What Leverage Remains?

The framework includes co-investment requirements — Kenya committed $850 million in increased domestic health spending — and broad language about health system strengthening [2]. But the specific enforcement mechanisms are thin. Without NGO monitoring and reporting on the ground, the US would rely primarily on Kenyan government self-reporting and periodic State Department reviews to ensure funds are used as intended.

The agreements establish five-year plans for 2026-2030 with stated goals of "helping countries move toward more resilient and durable health systems" [27]. But the cofinancing provisions vary so widely across the 30 signatory countries that it is unclear whether the US is applying a consistent standard or negotiating whatever terms each government will accept [14].

The Kenyan government, for its part, gains significant leverage. Direct funding frees it from NGO conditions around transparency, reporting, and programmatic priorities — including politically sensitive areas like HIV prevention among marginalized populations and democracy programming. The framework makes no explicit provisions governing benefit-sharing from data-derived innovations, and unlike the WHO's Pathogen Access and Benefit Sharing framework, offers no safeguards against data being combined with other datasets after it leaves Kenya's control [4].

The Road Ahead

The Kenya framework remains suspended by court order as of April 2026. The legal proceedings are ongoing, and the outcome will likely influence whether other African nations with similar data protection laws — an increasing number — challenge their own agreements [4].

The administration's stated goal of signing 50 bilateral agreements has reached 30 [14][27]. Implementation was supposed to begin in April 2026, but the Kenya court challenge, Zimbabwe's outright rejection, and Zambia's resistance suggest the rollout will be slower and more contested than planned [4].

For the 1.3 million Kenyans on antiretroviral treatment, the 41,500 health workers dependent on US funding, and the broader population that has benefited from a 78 percent reduction in new HIV infections over a decade, the stakes are concrete [7][8]. The question is not whether the NGO model had flaws — it did. The question is whether routing billions of dollars through government institutions with documented corruption problems, without independent monitoring, in a country whose own courts have found the arrangement constitutionally suspect, will produce better outcomes for the people the money is supposed to help.